4,4,5,5-Tetramethyl-2-(6-methylcyclohex-1-en-1-yl)-1,3,2-dioxaborolane, 98%, 500mg

2-(3,3-difluoropiperidin-1-yl)ethan-1-ol hydrochloride, 95.0%, 250mg

(2R,2'R,3R,3'R)-4,4'-Di(anthracen-9-yl)-3,3'-di-tert-butyl-2,2',3,3'-tetrahydro-2,2'-bibenzo[d][1,3]oxaphosphole, 97%, 100mg

(2E)-3-(furan-2-yl)-1-(2-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

4-Methyl-3-nitrobenzenesulfonyl Chloride>98.0%(GC)(T)5g

(2E)-1-(3-methoxyphenyl)-3-[4-(propan-2-yl)phenyl]prop-2-en-1-one, 95.0%, 2g

6-Bromo-7-nitro-2,3-dihydrobenzo[b][1,4]dioxine, 98%, 50g

1H-Pyrrolo[2,3-b]pyridine-2-carbaldehyde, 95.0%, 5g

2,3-Dihydro-2,2-dimethyl-7-hydroxybenzofuran>98.0%(GC)25g

trans-2-(4-Hydroxy-cyclohexyl)-isoindole-1,3-dione, 95.0%, 1g

Syringe filters CHROMAFIL® RC, 0,45 µm, 25 mm, 100 Piece(s)

(3-tert-Butoxycarbonylamino-pyrrolidin-1-yl)-acetic acid, 2.5g

(4-Fluoro-3-methylphenyl)(4-fluorophenyl)methanone, 97%, 5g